Bionano Genomics Inc. participated in the Association for Molecular Pathology $(AMP)$ Annual Meeting held in November 2025 in Boston, Massachusetts. At the conference, the company highlighted advances in its optical genome mapping (OGM) technology through presentations and posters. Researchers showcased the expanding applications of OGM in detecting structural variants for inherited diseases, reproductive disorders, hematological malignancies, and solid tumors. The event emphasized OGM's ability to complement traditional cytogenetic and molecular techniques, streamline laboratory workflows, and integrate into existing genomic analysis pipelines.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bionano Genomics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9600604) on December 11, 2025, and is solely responsible for the information contained therein.